Factor | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P -value | HR | 95% CI | P -value | |||
Overall survival | Â | Â | Â | Â | Â | Â | Â | Â |
Depth of invasion (T1-2/T3-4) | 2.07 | 1.16 | 3.69 | 0.014* | 1.82 | 0.98 | 3.38 | 0.060 |
Tumor stage (I-II/III-IV) | 2.01 | 1.11 | 3.63 | 0.021* | 1.37 | 0.72 | 2.6 | 0.333 |
Grade of differentiation (well, moderate/poor) | 2.13 | 1.01 | 4.45 | 0.046* | 1.28 | 0.53 | 3.05 | 0.581 |
Lymph node metastasis (negative/positive) | 4.68 | 2.45 | 8.94 | <0.001* | 3.47 | 1.66 | 7.27 | 0.001* |
Liver metastasis (negative/positive) | 3.53 | 1.88 | 6.63 | <0.001* | 2.62 | 1.29 | 5.32 | 0.008* |
Venous invasion (negative/positive) | 2.45 | 1.04 | 5.8 | 0.042* | 1.66 | 0.64 | 4.32 | 0.294 |
Nervous invasion (negative/positive) | 2.25 | 1.25 | 4.05 | 0.007* | 1.14 | 0.59 | 2.19 | 0.703 |
GDH (low/high) | 2.32 | 1.26 | 4.26 | 0.007* | 2.42 | 1.23 | 4.78 | 0.011* |
Disease-free survival | Â | Â | Â | Â | Â | Â | Â | |
Lymph node metastasis (negative/positive) | 5.73 | 2.68 | 12.28 | <0.001* | 4.70 | 2.08 | 10.59 | <0.001* |
Liver metastasis (negative/positive) | 3.81 | 1.95 | 7.46 | <0.001* | 2.38 | 1.16 | 4.87 | 0.018* |
GDH (low/high) | 2.48 | 1.25 | 4.92 | 0.009* | 2.17 | 1.05 | 4.47 | 0.037* |